Bactericidal activity of levofloxacin against Mycoplasma pneumoniae [3]

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 3, 2003, Pages 527-528

  Duffy, Lynn B ^a   Crabb, Donna M ^a   Bing, Xue ^a   Waites, Ken B ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Bactericidal activity; Fluoroquinolones; Levofloxacin; M. pneumoniae; Respiratory tract infections

Indexed keywords

LEVOFLOXACIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG DETERMINATION; IN VITRO STUDY; INOCULATION; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PNEUMONIA; RESPIRATORY TRACT DISEASE;

ANTI-BACTERIAL AGENTS; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA PNEUMONIAE; OFLOXACIN; PNEUMONIA, MYCOPLASMA;

EID: 0141517688     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg365     Document Type: Letter

References (6)

1. Talkington, D. T., Waites, K. B., Schwartz, S. et al. (2001). Emerging from obscurity: understanding the pathogenesis, associated syndromes, and epidemiology of Mycoplasma pneumoniae. In Emerging Infections 5 (Scheld, W. M., Craig, W. A. & Hughes, J. M., Eds), pp. 57-84. American Society for Microbiology, Washington, DC, USA.
2. Waites, K. B., Crabb, D. M., Bing, X. et al. (2003). In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrobial Agents and Chemotherapy 47, 161-5.
3. Bébéar, C. M., Renaudin, H., Bryskier, A. et al. (2000). Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas. Antimicrobial Agents and Chemotherapy 44, 1980-2.
4. Duffy, L. B., Crabb, D., Searcey, K. et al. (2000). Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. Journal of Antimicrobial Chemotherapy 45, Suppl. S1, 29-33.
5. Hamamoto, K., Shimizu, T., Fujimoto, N. et al. (2001). In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae. Antimicrobial Agents and Chemotherapy 45, 1908-10.
6. Kenny, G. E. & Cartwright, F. D. (2001). Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrobial Agents and Chemotherapy 45, 2604-8.